Background: A Grm2 cys407* stop codon mutation, which results in a loss of the metabotropic glutamate 2 (mGlu2) receptor protein, was identified as being associated with high alcohol drinking by alcohol-preferring (P) rats. The objectives of the current study were to characterize the effects of reduced levels of mGlu2 receptors on glutamate transmission and alcohol drinking.
B
RAIN GLUTAMATE TRANSMISSION has been implicated in the neurobiology of alcohol use disorder (AUD; Gass and Olive, 2008; Koob and Volkow, 2010) . Acute and repeated alcohol exposure can alter extracellular glutamate levels within the mesocorticolimbic (MCL) system (Ding et al., 2012; Kapasova and Szumlinski, 2008; Moghaddam and Bolinao, 1994; Selim and Bradberry, 1996) . Chronic alcohol drinking and dependence induce a hyperglutamatergic state characterized by increased extracellular glutamate levels within the MCL system in human alcoholics and rodents (Ding et al., 2013; Griffin et al., 2014; Hermann et al., 2012) . In the wake of these findings, efforts have been invested in the development of pharmacotherapy targeting glutamate receptors in both preclinical and clinical research (Olive, 2009; Olive et al., 2012) .
A recent genomic sequencing study identified a Grm2 cys407* stop codon mutation in the alcohol-preferring (P) rat, which results in a loss of functional metabotropic glutamate 2 (mGlu2) receptors (Zhou et al., 2013) , suggesting a possible association between the loss of mGlu2 receptors and a predisposition for high alcohol preference and consumption in the P rat. Such a notion was further supported by a follow-up study showing that Grm2 knockout mice exhibited higher voluntary alcohol consumption of 15 to 17% (but not of 3 to 13%) ethanol (EtOH) compared to wild-type mice (Zhou et al., 2013) . In addition, alcohol dependence is associated with reduced Grm2 mRNA expression in the infralimbic cortex and rescue of this deficit with virus-mediated overexpression attenuated heightened alcohol seeking in dependent male Wistar rats (Meinhardt et al., 2013) . Collectively, these findings suggest that the Grm2/mGlu2 receptor may play a significant role in alcohol drinking and seeking.
The mGlu2 receptor is mainly a presynaptic auto-receptor that provides feedback inhibitory regulation of synaptic glutamate release (Bell et al., 2016; Moussawi and Kalivas, 2010) . Loss of these receptors would hypothetically result in increased glutamate release, leading to increased basal extracellular glutamate levels. As alcohol drinking and dependence are associated with increased glutamate levels within the brain (Ding et al., 2013; Griffin et al., 2014; Hermann et al., 2012) , it is possible that high alcohol drinking in the P rat compared to the Wistar rat may be due to greater basal extracellular glutamate levels in the P rat than the Wistar rat due to the loss of mGlu2 receptors. Such possible neurochemical differences may be manifested most likely in brain systems strongly implicated in the development of AUD, for example, the MCL system (Gonzales et al., 2004; Koob et al., 1998) . Therefore, the current study measured basal extracellular glutamate levels in Wistar and P rats using a quantitative microdialysis procedure in key regions of the MCL system, that is, the prelimbic (PL) cortex and nucleus accumbens shell (NACsh).
Altered glutamate transmission within the medial prefrontal cortex (mPFC) has been linked to alcohol dependence in alcoholics and rodents (Hermann et al., 2012) . The PL cortex of the mPFC projects extensively to and regulates activities of various key MCL regions, including the NAC and ventral tegmental area, among others (Heidbreder and Groenewegen, 2003; Vertes, 2004) . Accumulating evidence suggests an important role of the PL cortex in the development of AUD, as pharmacological manipulations of the PL cortex can regulate alcohol self-administration and drinking (Faccidomo et al., 2016; Samson and Chappell, 2001; Seif et al., 2013; Warnault et al., 2016) . Therefore, it is possible that the PL cortex may be an anatomical site underlying a possible association between the loss of mGlu2 receptors and elevated alcohol drinking. This study investigated this possibility by examining the effects of genetic manipulation of mGlu2 receptor expression, using lentiviral-mediated, short-hairpin RNA (shRNA)-induced RNA interference, on voluntary alcohol consumption by Wistar rats.
A recent study by Wood and colleagues (2017) reported that the Grm2 cys407* mutation was prevalent in some strains of Wistar rats of Hannover origin and rats selectively bred for particular behaviors, with various frequencies of the mutant allele. If there is an association between the Grm2 genetic variations and level of alcohol drinking, then rats carrying this stop codon mutation should exhibit higher alcohol consumption compared to rats without this mutation. As the levels of EtOH intake were not provided in the Wood and colleagues (2017) study, this study searched the literature for levels of EtOH intake for these rodents and examined the relation between the Grm2 cys407* allele frequency and alcohol drinking using a linear regression procedure.
The hypotheses tested in the current study were (i) basal extracellular glutamate levels within key MCL regions will be greater in P than Wistar rats; (ii) reduction of mGlu2 receptors within the PL cortex will increase voluntary alcohol drinking by Wistar rats; and (iii) there will be a significant correlation between the Grm2 cys407* mutant allele frequency and alcohol intake levels.
MATERIALS AND METHODS

Animals
Adult P (Indiana University) and Wistar rats (Harlan Inc., Indianapolis, IN) were housed in pairs in temperature-and humidity-controlled rooms maintained on a regular 12-hour light-dark cycle (light on at 7:00 AM) with food and water available ad libitum. Female rats were used in the microdialysis study as previously described (Ding et al., 2012 (Ding et al., , 2013 Engleman et al., 2011) . The estrous cycle was not monitored. Microdialysis was conducted in one side of the brain on 1 day and the other side on the next day in a counterbalanced manner. Therefore, any effect of a given phase of the estrous cycle should be distributed across cohorts. Adult male HAD1&2 and LAD1&2 rats were genotyped for Grm2 alleles. Protocols were approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine. All experiments were conducted in accordance with principles outlined in the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) .
Quantitative No-Net-Flux Microdialysis and Histology
Alcohol-na€ ıve female P and Wistar rats (n = 5 to 8/group) were compared in the microdialysis study. Alcohol-nonpreferring (NP) rats were not used because these rats have a blood-clotting deficiency that results in excessive bleeding following surgeries. Therefore, Wistar rats were used for comparisons with P rats when stereotaxic surgeries are required (Engleman et al., 2009; Katner et al., 2011; Rodd et al., 2004) .
Rats were stereotaxically implanted with dual guide cannula (18-gauge; Plastics One, Inc., Roanoke, VA), one aimed at the PL cortex (AP +3.0 mm, ML +0.7 mm, DV À5.0 mm) and the other at the contralateral NACsh (AP +1.7 mm, ML +2.3 mm, DV À8.5 mm; 10 o angle away from the vertical line) according to the brain atlas of Paxinos and Watson (1998) . The selection of these 2 regions was based on evidence indicating dense projections from the PL cortex to the NACsh (Vertes, 2004) and their implication in the AUD (Koob and Volkow, 2010) . Rats were individually housed following surgery and were allowed to recover for at least 5 days. Microdialysis probes (active membrane length 1.0 mm, inner diameter 200 lm, molecular weight cutoff: 13,000; Spectrum Laboratories, Inc, Rancho Dominguez, CA) were constructed and inserted into the target regions 16 to 18 hours prior to the sample collection.
Microdialysis was conducted over 2 consecutive days with one side at a time, counterbalanced, as previously described (Ding et al., 2012 (Ding et al., , 2013 . Briefly, rats were connected to a Harvard pump with PE20 tubing (inner diameter 0.38 mm; Becton Dickinson & Co., Franklin Lakes, NJ). Microdialysis started with a 90-minute washout period during which artificial cerebrospinal fluid (aCSF: 140.0 mM NaCl, 3.0 mM KCl, 1.2 mM CaCl 2 , 2.0 mM Na 2 H-PO 4 Á7H 2 O, 1.0 mM MgCl 2 , pH 7.2 to 7.4) was perfused through the probes, followed by collection of 4 to 5 baseline samples. Then, 4 different concentrations of glutamate (1, 5, 10 or 20 lM in aCSF) were perfused through the probes in a random order. Each concentration was perfused for 25 minutes. After the perfusion of the last glutamate concentration, the perfusion medium was changed to aCSF for an additional 20 minutes. Samples were collected every 5 minutes at a flow rate of 2.0 ll/min. Samples were frozen at À70°C until glutamate analysis.
At the end of microdialysis, rats were euthanized with an overdose of CO 2 inhalation, and 1% bromophenol blue was perfused through probes. Brains were quickly removed and frozen immediately on dry ice and stored at À70°C. Sections (40 lm) were sliced on a cryostat microtome and stained with cresyl violet for verification of probe placements.
Glutamate Analysis
Dialysate glutamate was analyzed with a reversed-phase highperformance liquid chromatography system with electrochemical detection, as previously described (Ding et al., 2012 (Ding et al., , 2013 (Ding et al., , 2016 . Briefly, precolumn derivatization with o-phthalaldehyde (Pickering Laboratory, Inc, Mountain View, CA) was performed using an ESA Model 542 autosampler (ESA Inc., Chelmsford, MA). The mobile phase consisted of 25% methanol (v/v) and 100 mM Na 2 H-PO 4 .7H 2 O, pH 6.75 (Sigma, St. Louis, MO) and was delivered by an ESA 582 solvent delivery system. Dialysis samples were injected onto a reversed-phase column (BDS Hypersil C18 Pioneer, 150 9 2 mm; Thermo Fisher Scientific, Waltham, MA), and glutamate was separated and detected with a BAS LC-4C amperometric detector with the oxidation potential set at +550 mV and the sensitivity set at 0.2 lA. The output from the detector was sent to a ChromPerfect chromatography data analysis system (Justice Laboratory Software, Denville, NJ). The concentration of glutamate was quantified by comparing the area under the peak with an external standard curve.
Generation and Verification of Lentiviral Vectors
The siDesign Center program (Thermo Fisher Scientific) was used to identify three 19-nucleotide small interfering RNAs targeting the rat Grm2 transcript (NCBI accession number NM_001105711). DNA oligonucleotides encoding shRNAs containing the 19-nucleotide targeting sequences were synthesized and cloned into the lentiviral vector pLL3.7 as previously described (Lasek et al., 2007) . To validate the effectiveness of the shRNAs, lentiviral plasmids were cotransfected with a plasmid encoding the Grm2 cDNA (graciously provided by Dr. Wolfgang Sommer, Central Institute of Mental Health, Mannheim, Germany) into Neuro-2a cells and Grm2 mRNA expression was measured using quantitative real-time PCR (qPCR) 2 days after transfection. The 2 most effective shRNAs, that is, shGrm2-972 and shGrm2-2344, contained the targeting sequences 5 0 -GCAGAAACCCAGTGCC CGT-3 0 and 5 0 -GTGGTGACATTGCGCTGTA-3 0 , respectively. Lentiviruses were produced from these constructs in 293FT cells by cotransfection with packaging plasmids. Control (scrambled) lentivirus was the same as we have used before and is not predicted to target any gene in the rat genome (Lasek et al., 2007) . Viral titers were obtained using the p24 antigen ELISA kit (Zeptometrix, Buffalo, NY) and ranged from 2 9 10 7 to 3 9 10 7 pg/ml.
Microinjection of Lentiviral Vectors
Surgery followed a similar procedure previously described with an adaptation of the cannulation procedure (Lasek and Azouaou, 2012) . Specifically, the infusion cannula system in the study of Lasek and Azouaou (2012) consisted of a 33-gauge hypodermic tube inserted into a 26-gauge tube; the system was then attached to the insertion tool and was lowered into the target brain region during surgery. This procedure could be readily adapted to our stereotaxic instruments. Briefly, a 26-gauge guide cannula was inserted, aimed 1 mm above the target region, and was secured with dental cement on the surface of skull. Then, a 33-gauge hypodermic tube was lowered into the target region through the guide cannula for virus infusion. The guide cannula was removed following the completion of infusion. This procedure has been successfully implemented in our previous studies involving microinjection of lentiviral vectors into discrete brain regions (Franklin et al., 2015a,b) . In the present study, alcohol-na€ ıve adult male Wistar rats were implanted with dual guide cannulas (26-gauge; Plastics One, Inc.) aimed 1 mm above the contralateral PL cortex (AP +3.0 mm, ML +2.0 mm, DV À5.3 mm, with a 20 o angle away from the vertical line). Stainless steel hypodermic tubes (33-gauge; Plastics One, Inc.), connected to 25-ll Hamilton syringes with PE-20 tubing, were then inserted through the guide cannulas into the PL cortex. The syringes were placed in a micro-infusion pump for controlled delivery of lentiviral vectors. The vector solution was infused for 1.5 ll/side at a rate of 0.2 ll/min. The 33-gauge tubes were left in place for another 10 minutes before being slowly removed. The guide cannulas were then removed, and the scalp was closed and stapled with stainless steel wound clips. The rats were randomly assigned to 1 of 3 groups (the scrambled, shGrm2-972, and shGrm2-2344; n = 9 to 10/group). Following the delivery of the vectors, rats were quarantined for 72 hours followed by general housing for 6 weeks before alcohol drinking was initiated. Previous studies suggested that significant effects typically occurred 5 to 6 weeks after the shRNA infusion (Franklin et al., 2015a,b) .
Voluntary EtOH Consumption
Following the quarantine, male Wistar rats were transferred to metal hanging cages and were individually housed throughout the experiment. After 1 week of acclimation, rats received 24-hour continuous access to EtOH with a 3-bottle choice paradigm (10 and 15% EtOH vs. water) for 5 weeks followed by 24-hour intermittent access on Mondays, Wednesdays, and Fridays for 3 weeks. The EtOH solution was made by mixing 95% EtOH (McCormick Distilling, Weston, MO) with water to the final concentrations. The intermittent access is a validated procedure to achieve high alcohol consumption in outbred rats (Carnicella et al., 2014; Simms et al., 2008) . The positions of EtOH and water bottles were randomly alternated every week, and fluid intake was recorded to the nearest 0.1 g by weighing bottles 3 times a week, at the same time body weights were taken. EtOH intake was converted to grams of EtOH per kilogram of body weight (grams per kilogram per day). Following the last drinking session, rats were euthanized by CO 2 overdose; brains were quickly removed and immediately frozen at À70°C until Western blot analysis.
Western Blot
Basal levels of mGlu2 receptors were examined within the PL cortex and NACsh of alcohol-na€ ıve female Wistar and P rats (n = 3/ group). In addition, mGlu2 receptors were determined in the PL cortex of male Wistar rats from the viral vector experiment. Brain tissue was micropunched from the target regions as previously described (Ding et al., 2013; McBride et al., 2009) . Tissue was transferred to a RIPA protein extraction buffer (Thermo Fisher Scientific) containing protease inhibitors (Roche Diagnostics, Indianapolis, IN), homogenized, and centrifuged at 11,7529g at 4°C for 20 minutes. The supernatant was separated and protein concentrations were measured using the Pierce BCA assay (ThermoScientific, Rockford, IL). Western blot for the mGlu2 receptor and GAPDH was conducted as previously described (Ding et al., 2013) . Briefly, approximately 10 lg of protein was loaded and separated on Bolt 4 to 12% Bis-Tris mini gels (Thermo Fisher Scientific), followed by transfer onto polyvinylidene difluoride membranes (Merck Millipore Ltd., Billerica, MA). Blots were probed with mouse anti-mGlu2 receptor (ab15672, 1:1,000; Abcam, Cambridge, MA) or mouse anti-GAPDH (G8795, 1:10,000; Sigma-Aldrich) antibody. The blots were then probed with a goat anti-mouse IRDye 
Genotyping of HAD1/2 and LAD1/2 Rats
Blood samples were genotyped at the Alcohol Research Center at Indiana University as previously described (Hendershot et al., 2009) . Briefly, genomic DNA was isolated with the "HotSHOT" method followed by a multiplexed, end point, allelic discrimination assay using TaqMan probes (Applied BioSystems, Foster City, CA). Each assay mix contained 2 different TaqMan probes, labeled with VIC or FAM fluorescent reporter dye, which bind preferentially to one of the alleles. Each reaction contained 5 ll of 29 TaqMan Universal PCR Mastermix, No AmpErase UNG, 3.75 ll of water, 0.25 ll of 409 Assay Mix, and 1 ll of DNA sample. Eight or 11 control samples were included in each 96-well plate: 2 no template controls, 2 or 3 heterozygous samples, and 2 or 3 of each of the homozygous samples. After PCR, the PCR products were analyzed in an ABI PRISM Ò 7300 Sequence Detection System (SDS) instrument (Thermo Fisher Scientific). The raw data were converted with SDS Software 1.3.1 for plots of the allelic discrimination.
Statistical Analysis
No-net-flux (NNF) data were analyzed with multiple linear regressions, as previously described (Ding et al., 2012 (Ding et al., , 2013 . [Glu in ] and [Glu out ] were defined as glutamate concentrations perfused and obtained from dialysates, respectively. [Glu in -Glu out ], defined as the net gain or loss of glutamate, was plotted on the "y"-axis with [Glu in ] on the "x"-axis. The slope (the extraction fraction [Ed] ) and the x-intercept (the NNF point as the extracellular glutamate concentration) were determined by multiple linear regressions modeling and analyzed with analysis of variance (ANOVA) using the SAS System for Windows, version 8.02 (SAS Institute Inc., Cary, NC). Alcohol drinking data were analyzed with a time 9 treatment ANOVA. Western blot data were analyzed with a 1-way ANOVA or student t-tests. Linear regression was used to analyze the correlation between Grm2 mutant allele frequency and alcohol intake. Post hoc Tukey's b analysis was conducted where appropriate.
RESULTS
Basal Extracellular Glutamate Levels and mGlu2 Receptors Within the PL Cortex and NACsh
In the PL cortex, extracellular glutamate concentrations (NNF points) were 6.4 AE 0.6 lM in female Wistar rats and 3.6 AE 0.6 lM in female P rats. Wistar rats had significantly higher basal glutamate levels than P rats, F(1, 199) = 3.94, p < 0.05; Fig. 1A ,B. The Eds (slopes of the regression lines) were 32 AE 5% in Wistar rats and 42 AE 5% in P rats (Fig. 1A,B) . There was no significant difference in the Eds between groups, F(1, 198) = 1.91, p = 0.16.
In the NACsh, extracellular glutamate concentrations were 6.6 AE 0.6 lM for Wistar rats, and 3.2 AE 0.4 lM for P rats, with significantly higher concentrations in Wistar than P rats, F(1, 222) = 14.6, p < 0.001; Fig. 2A,B . On the other hand, the Eds were significantly greater in P rats than Wistar rats (45 AE 3% vs. 28 AE 3%, respectively; F(1, 221) = 15.3, p < 0.001; Fig. 2A,B) .
Representative placements of probes within the PL cortex and NACsh are shown in Figs 1C and 2C . To be included, the probes should have at least 75% of the active membrane within the target area. Approximately 85% of rats fulfilled the criteria and were included in the analysis.
Basal protein levels of mGlu2 receptors in the NACsh and PL cortex were assessed in separate groups of rats, and the results are presented in Fig. 3 . The mGlu2 receptor protein was expressed in both regions of female Wistar rats. On the other hand, neither region of female P rats had detectable levels of mGlu2 receptor expression, confirming the finding reported in Zhou and colleagues' study (2013).
Grm2 shRNAs and Voluntary Alcohol Consumption
Alcohol drinking following micro-infusion of lentiviruses expressing either the scrambled or Grm2 shRNAs into the PL cortex of male Wistar rats is shown in Fig. 4A . With continuous access, average daily intake was~1 g/kg/d during week 1 and gradually increased to~3 g/kg/d at the end of week 5. During intermittent access, averaged daily intake was~4.5 g/kg/d during week 6 and reached~5.5 g/kg/d at the end of week 8. Repeated measures ANOVA revealed a significant effect of time, F(7, 19) = 14.8, p < 0.001, but no significant effect of treatment, F(2, 25) = 0.2, p = 0.82, or time 9 treatment interaction, F(14, 40) = 1.3, p = 0.26. The significant effect of time was due in part to the significant increase in alcohol intake when rats were switched from continuous access to intermittent access. Neither Grm2 shRNA had a significant effect on alcohol intake.
Brain tissues from the PL cortex were micropunched following the cessation of the last drinking session, and levels of mGlu2 receptor protein were analyzed with Western blots. The results indicate that both Grm2 shRNAs reduced mGlu2 receptor expression by~40% compared to the scrambled shRNA ( Fig. 4B ; F(2, 25) = 20.6, p < 0.001).
These shRNAs were also validated in vitro on Grm2 mRNA expression. Both Grm2 shRNAs significantly reduced mRNA expression in cultured cells, F(2, 6) = 12.5, p = 0.007. shGrm2-972 and shGrm2-2344 reduced mRNA expression to 32 AE 14% and 41 AE 18% of levels seen with the scrambled shRNA, respectively (Fig. 4B ). There were no significant differences between the 2 Grm2 shRNAs in this regard. Table 1 depicts genotypic data for the Grm2 cys407* allele frequency and the corresponding alcohol intake levels in rodents obtained from a literature search. There were a total of 36 different strains, with 34 rat strains and 2 mouse strains. Twelve strains did not carry the Grm2 cys407* stop codon mutation: ANA, NP, LAD1, sNP, ACI/N, WKY/N, F344/ N, BN/Ssn, 407C/C, Grm2+/+, Hsd:WI, and RLA-1. Average alcohol intake ranged from 0.3 to 3.2 g/kg/d. Fifteen strains were homozygous for the Grm2 cys407* mutation: P, HAD1, HAD2, LAD2, BUF/N, M520/N, MR/N, WN/N, 407*/*, Grm2À/À, BkI/WI, HsdHan:W, RHA-I, HAB, and LAB. Average alcohol intake ranged from 0.5 to 5.7 g/kg/d. Among these, 7 strains exhibited average alcohol intake <2.0 g/kg/d. In addition, there were 9 strains in which the mutant allele frequency varied between 0.04 and 0.99: AA, CrL:WI, RjHan:WI, WLP, WHP, 407C/*, sP, HanTac:W, and RccHan:W. Average alcohol intake ranged from 0.4 to 7.8 g/kg/d. Figure 5 shows the linear regression analysis between the mutant allele frequency and average alcohol intake. The analysis revealed no significant correlation between alcohol intake levels and the mutant allele frequency, F(1, 35) = 3.1, p = 0.09, with the correlation coefficient (R) value at 0.29 and the coefficient of determination (R 2 ) value at 0.09. The data suggest that the mutant allele frequency cannot predict alcohol intake levels.
Linear Regression of the Grm2 Mutant Allele Frequency and Alcohol Intake
DISCUSSION
The major findings of the current study indicate (i) basal extracellular glutamate levels within the PL cortex and NACsh were lower in female P rats than female Wistar rats;
(ii) lentiviral-mediated shRNA-induced knockdown of mGlu2 receptors within the PL cortex did not significantly alter voluntary alcohol consumption in male Wistar rats; and (iii) no significant correlation was found between the Grm2 cys407* mutation and alcohol drinking in rodents. These results do not support our original hypotheses. Instead, they suggest that there is no significant association between the loss of Grm2/mGlu2 receptors and glutamate transmission, and between reduced levels of mGlu2 receptors in the PL cortex and alcohol drinking.
Protein analysis confirmed a lack of mGlu2 receptor expression within the NACsh and PL cortex of female P rats, but not of female Wistar rats (Fig. 3) . Due to its autoreceptor nature, the loss of mGlu2 receptors would hypothetically lead to higher extracellular glutamate concentrations within these regions. However, the results indicate the extracellular glutamate levels were significantly lower in these 2 regions of P than Wistar rats (Figs 1 and 2) . The basal glutamate concentrations within the NACsh were consistent with a previous study conducted in P rats (Ding et al., 2013) . These results suggest that the loss of mGlu2 receptors may not be associated with high extracellular glutamate transmission. It should be noted that extracellular glutamate levels are regulated not only by the mGlu2 receptor, but also by other factors, for example, glutamate transporters that are responsible for glutamate clearance (Danbolt, 2001) , glutamate release from neurons following depolarization, and glutamate release from glial cells through the cystineglutamate antiporter, which contributes to majority of extracellular glutamate levels (Baker et al., 2002) . Compensatory changes in these processes may also contribute to lower extracellular glutamate levels in P rats. For example, the lower extracellular glutamate levels in P rats are accompanied by greater Ed values in the NACsh (Fig. 2B) , which suggests that enhanced glutamate clearance may have overcome the effects produced by the loss of mGlu2 receptors in this region. In addition, reduced glutamate release may also contribute to lower the extracellular glutamate levels in the PL cortex.
A previous study indicated that basal extracellular glutamate levels within the PFC and NAC were lower in Lewis than Fischer 344 rats (Selim and Bradberry, 1996) . EtOH has been shown to be more reinforcing in Lewis than Fischer 344 rats, and Lewis rats self-administer more EtOH than Fischer 344 rats (Cadoni, 2016) . These findings, along with the current results, suggest that extracellular glutamate levels may be associated with alcohol self-administration and drinking. The physiology of differential extracellular glutamate levels between P and Wistar rats and their contributions to the predisposition to alcohol preference and consumption remain unknown. It is possible that the lower basal glutamate transmission in P rats may render the glutamate system in these rats more susceptible to perturbations induced by alcohol, resulting in heightened alcohol-glutamate interactions that drive and precipitate further alcohol drinking.
The lentiviral-mediated shRNAs significantly decreased Grm2 mRNA expression by~60 to 70% in cultured cells and reduced mGlu2 receptor protein levels by~40% within the PL cortex of male Wistar rats (Fig. 4B) . Nonetheless, there were no significant differences in voluntary alcohol drinking between rats treated with the scrambled shRNA and rats treated with the active Grm2 shRNAs during either continuous or intermittent EtOH access (Fig. 4A) . It is noted that a previous study demonstrated that antagonism of mGlu2/3 receptors with LY341495 escalated alcohol self-administration in Wistar rats (Zhou et al., 2013) . Differences in experimental procedures may have contributed to the different results, for example, systemic versus central administrations, and genetic versus pharmacological manipulations. Another possibility for the current findings is that alteration of glutamate transmission within the PL cortex may not be involved in alcohol drinking. However, previous studies demonstrated an important role of the PL cortex, in general (Faccidomo et al., 2016; Samson and Chappell, 2001; Warnault et al., 2016) , and glutamate transmission within the PL cortex, in particular (Seif et al., 2013) , in alcohol drinking. Furthermore, the magnitude of mGlu2 receptor knockdown (~40%) may not be sufficient to alter drinking behavior. Such a possibility cannot be tested at the current stage due to technical limitations. In the foreseeable future, however, new technology may evolve and enable such a study, for example, conditional knockout of Grm2/mGlu2 receptor powered by the latest genetic editing tools such as CRISPR-Cas9. It should be noted that the loss of mGlu2 receptors may have induced compensatory changes during development, for example, reduced glutamate release and/or increased glutamate re- Fig. 4 . (A) Effects of microinjection of lentiviral shRNAs into the prelimbic cortex on alcohol drinking in male Wistar rats (n = 9 to 10/group) given continuous access (CA) for 5 weeks and intermittent access (IA) for 3 weeks to alcohol under a 3-bottle choice condition (10 and 15% ethanol vs. water). (B) Effects of shRNAs on expression levels of Grm2 mRNA in vitro and mGlu2 receptor (mGluR2) protein in vivo. *p < 0.05, #p < 0.05, significantly lower than the corresponding "scrambled" group. Inset: SG: scrambled; Sh1: shGrm2-972; Sh2: shGrm2-2344. uptake, which may contribute to the high alcohol preference and consumption in P rats, whereas the knockdown of mGlu2 receptors during adulthood in Wistar rats may not allow similar compensatory changes to develop, thus preventing enhanced alcohol drinking. Alternatively, some studies suggest that the involvement of the mGlu2 receptor may be dependent on the stage of AUD. For example, Augier and colleagues (2016) reported that the selective mGlu2 receptor-positive allosteric modulator AZD8529 significantly reduced reinstatement of alcohol seeking with only marginal effects on alcohol self-administration. In addition, Meinhardt and colleagues (2013) found that alcohol dependence reduced Grm2 mRNA expression in the infralimbic cortex and rescue of this deficit attenuated the reinstatement of alcohol seeking specifically in dependent, but not nondependent, rats.
A shortcoming of the current study was that female rats were used in the microdialysis experiments and male rats were used in the shRNA experiment. The male Wistar rats were used in the viral vector experiment to match male Wistar rats used in the study by Meinhardt and colleagues (2013) .
Similar to P versus NP rats, there appeared to be an association between Grm2 and alcohol drinking in sP versus sNP rats (Colombo et al., 2006; Wood et al., 2017) . However, this association did not appear to generalize to other strains of rodents (Table 1) , as the linear regression analysis found no significant correlation between Grm2 mutant allele frequency and alcohol intake levels by different rodent lines (Fig. 5) . In particular, the Low Alcohol Drinking Replicate line 2 (LAD2) is homozygous for the Grm2 cys407* mutation, whereas only a fraction of the Alko Alcohol-preferring rats (AA) carried the mutant allele (frequency: 0.04). These results suggest that the loss of Grm2/mGlu2 receptors alone may not predict high alcohol drinking.
Collectively, the current experiments do not support a significant association between the loss of the Grm2/mGlu2 receptor and higher glutamate transmission in the PL cortex and NACsh of female P rats, and between the reduction of mGlu2 receptor protein in the PL cortex and alcohol drinking in male Wistar rats. This latter finding is in contrast to findings by Zhou and colleagues (2013) . However, the Zhou and colleagues (2013) reported on the effects of a total loss of mGlu2 receptors throughout all tissues, whereas only the PL cortex was examined in the present study. Furthermore, numerous other genetic, neurochemical, and molecular differences have been found between P and NP rats (Bell et al., 2012; McBride and Li, 1998; Murphy et al., 2002) . Genetic studies also point to the genetic heterogeneity of alcoholism with potential involvement of a cluster of genes (Crabbe et al., 2006; Reilly et al., 2017) . Therefore, it is likely that the Grm2/ mGlu2 receptor, as a contributing rather than determining factor, works in concert with a host of genetic and molecular substrates to shape the bidirectional drinking phenotypes manifested in P and NP rats.
In summary, the results of the current study suggest a lack of association between the loss of the Grm2/mGlu2 receptor and glutamate transmission within key corticolimbic regions of female P rats, reduction of the levels of mGlu2 receptors within the PL cortex, and alcohol drinking by male Wistar rats, and no correlation between frequency of the Grm2 cys407* stop codon mutation and the level of alcohol intake in rodents. However, there is evidence suggesting the involvement of the mGlu2 receptors in the reinstatement of alcohol seeking, particularly following dependence (Augier et al., 2016; Meinhardt et al., 2013) . These are particularly relevant to these 2 stages of the conceptualized addiction cycle: withdrawal/negative affect and preoccupation/anticipation stages (Koob and Volkow, 2016) . Therefore, future studies will need to examine the involvement of the Grm2/mGlu2 receptor in these 2 stages using appropriate animal models; such work will increase our knowledge regarding the role of the Grm2/mGlu2 receptor in the development of AUD and aid in the development of medications targeting the Grm2/ mGlu2 receptor.
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